HDAC9 and melanoma: In addition, HDAC inhibitors might decrease the release of immunosuppressive cytokines and chemokines, thus enhancing the effectiveness of immune checkpoint inhibitors, which have significantly transformed the treatment of melanoma in recent years [69].